arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2307.09405stat.AP
收藏

化疗接受剂量强度对生存结局的因果效应:一项骨肉瘤回顾性研究

Causal effect of chemotherapy received dose intensity on survival outcome: a retrospective study in osteosarcoma

Marta Spreafico, Francesca Ieva, Marta Fiocco

AI总结:

针对骨肉瘤化疗中RDI降低受毒性混杂影响的问题,研究基于BO03/BO06试验数据,用IPTW、边际结构Cox模型和CATE评估因果效应,发现组织学反应对生存效应具有显著修饰作用。

摘要:

本研究旨在采用一种新方法分析降低骨肉瘤患者化疗接受剂量强度(RDI)对其生存的影响。在此情境中,毒副作用既是死亡的风险因素,又是未来暴露水平的预测因素,从而引入分配后混杂。研究使用骨肉瘤BO03和BO06随机临床试验(RCT)的化疗给药数据,模拟一项目标试验,该试验包含三种基于RDI的暴露策略:1)标准RDI,2)降低RDI,以及3)高度降低RDI。研究在以组织学反应(HRe)较差或较好为特征的患者亚组之间开展调查。首先使用逆概率治疗加权(IPTW)将原始人群转换为模拟目标随机队列的伪人群。随后,采用带效应修饰的边际结构Cox模型。最终,将条件平均处理效应(CATE)衡量为降低或高度降低RDI策略与标准RDI策略的限制平均生存时间之差。CATE的置信区间通过一种新的基于IPTW的自助法程序获得。研究发现了基于HRe的显著效应修饰。增加RDI降低程度在反应较差和反应较好者中导致相反趋势:降低程度越高,反应较差者的生存越好,而反应较好者的生存越差。本研究引入了一种新方法,以(i)全面应对与化疗数据分析相关的挑战,(ii)减轻毒性—治疗—调整偏倚,以及(iii)将现有RCT数据重新用于超出原试验预期范围的回顾性分析。

英文摘要:

This study aims to analyse the effects of reducing Received Dose Intensity (RDI) in chemotherapy treatment for osteosarcoma patients on their survival by using a novel approach. In this scenario, toxic side effects are risk factors for mortality and predictors of future exposure levels, introducing post-assignment confounding. Chemotherapy administration data from BO03 and BO06 Randomized Clinical Trials (RCTs) in ostosarcoma are employed to emulate a target trial with three RDI-based exposure strategies: 1) standard, 2) reduced, and 3) highly-reduced RDI. Investigations are conducted between subgroups of patients characterised by poor or good Histological Responses (HRe). Inverse Probability of Treatment Weighting (IPTW) is first used to transform the original population into a pseudo-population which mimics the target randomized cohort. Then, a Marginal Structural Cox Model with effect modification is employed. Conditional Average Treatment Effects (CATEs) are ultimately measured as the difference between the Restricted Mean Survival Time of reduced/highly-reduced RDI strategy and the standard one. Confidence Intervals for CATEs are obtained using a novel IPTW-based bootstrap procedure. Significant effect modifications based on HRe were found. Increasing RDI-reductions led to contrasting trends for poor and good responders: the higher the reduction, the better (worsen) was the survival in poor (good) reponders. This study introduces a novel approach to (i) comprehensively address the challenges related to the analysis of chemotherapy data, (ii) mitigate the toxicity-treatment-adjustment bias, and (iii) repurpose existing RCT data for retrospective analyses extending beyond the original trials' intended scopes.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑